期刊文献+

苦瓜皂甙预防去卵巢大鼠骨质疏松的实验研究 被引量:5

Preventive Effect of Momordica charantia L.Saponins on Osteoporosis in Ovariectomized Rats
下载PDF
导出
摘要 以去卵巢骨质疏松症模型大鼠为研究对象,以血清参数、骨密度(BMD)、股骨和子宫组织形态为指标,研究连续给与苦瓜皂甙65、130、260mg/(kgbw·d)12周后对去卵巢大鼠骨质疏松的预防作用。结果表明:苦瓜皂甙用药组大鼠与模型组相比较血清雌二醇、Ca2+水平提高,股骨骨密度提高,股骨近端干骺端骨组织形态得到改善,而体质量、子宫质量以及子宫组织形态与模型组大鼠无显著差异。因此,苦瓜皂甙可预防去卵巢大鼠骨质疏松的形成。 To consider the potential of Momordica charantia L.saponins in preventing osteoporosis,female SD ovariectomized rats with osteoporosis were used as experimental animals.The rats were divided into 4 groups designated as one model and 3 experimental groups administered Momordica charantia L.saponins at the doses of 65,130 mg/(kg bw·d) and 260 mg/(kg bw·d) for 12 consecutive weeks.After the administration,blood parameters and bone mineral density(BMD) of rats were measured and pathomorphism of femur and uterus were observed as well.Compared with the osteoporosis model group,serum E2 and Ca2+ levels and bone mineral density(BMD) of the experimental groups exhibited an obvious increase.Wider trabecular bone and smaller medullary cavity were also observed in the experimental groups.However,no difference in body weight,uterus weight and uterus pathomorphism was observed between rats with and without Momordica charantia L.saponins treatments.The above findings demonstrate a preventive effect of Momordica charantia L.saponins on osteoporosis in ovariectomized rats.
出处 《食品科学》 EI CAS CSCD 北大核心 2010年第7期272-275,共4页 Food Science
基金 常熟理工学院"海藻遗传与种质创新"重点实验室开放基金项目(KY2009004)
关键词 苦瓜皂苷 骨质疏松 大鼠 Momordica charantia L.saponins osteoporosis rats
  • 相关文献

参考文献11

  • 1程光文,陈青山,张绪忠,唐跃华.苦瓜对小鼠免疫功能的影响[J].中草药,1995,26(10):535-536. 被引量:26
  • 2SARKAR S, PRANAVA M, MARITA R. Demonstration of the hypoglyeemicaetion of Momordica charantia in validated animal model of diabetes[J]. Pharmacol Res,1996, 33(1): 1-4.
  • 3ALMED I, ADEGHATE E, SHARMA A K, et al. Effects of Momordicacharantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat[J]. Diabetes Res Clin Pratt,1998, 40(3): 145-151.
  • 4王先远,高兰兴.苦瓜提取物MAP30抗病毒的研究进展[J].氨基酸和生物资源,2000,22(2):6-11. 被引量:24
  • 5李朝阳,李青南,吴铁,黄连芳.中药补骨2号对去势雌大鼠密质骨代谢影响的定量研究[J].中成药,1994,16(10):32-34. 被引量:21
  • 6INZERILLO A M, ZAIDI M, HUANG C L. Calcitonin: physiological actions and clinical applications[J]. J Pediatr Endocrinol Metab, 2004, 17: 931-940.
  • 7林燕萍,周瑞祥,王和鸣,冯尔宥.卵巢切除与血清肿瘤坏死因子-α、转化生长因子-β_1浓度的关系[J].中华老年医学杂志,2002,21(4):275-277. 被引量:8
  • 8HELENIUS J K. Tissue-selectivity: the mechanism of action of tibolone [J]. Maturitas, 2004, 48: 30-36.
  • 9REGINSTER J Y, SARKAR S, ZEGELS B, et al. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fractuer risk[J]. Bone, 2004, 34:344-351.
  • 10PALACIOS S, FARIAS M L, LUEBBERT H, et al. Raloxifene is not associated with biologically relevant changes in hot flushes in post- menopausal women for whom therapy is appropriate[J]. Am J Obstet Gynecol, 2004, 191: 121-131.

二级参考文献19

  • 1薛建华,上海免疫学杂志,1989年,9卷,6期,48页
  • 2张子康,医学微生物学与免疫学实验教程,1989年
  • 3徐叔云,药理实验方法学,1982年
  • 4Schreiber C A,Fertility Sterility,1999年,72卷,4期,686页
  • 5Bourinbaiar A S,Biochem Biophys Res Commun,1996年,219卷,3期,923页
  • 6Bourinbaiar A S,Biochem Biophys Res Commun,1995年,208期,779页
  • 7Lee Huang S,Gene,1995年,161卷,2期,151页
  • 8Lee Huang S,Proc Nat1 Acad Sci USA,1995年,92期,8818页
  • 9Lee Huang S,J Mol Biol,1994年,240期,92页
  • 10Lee Huang S,Proc Natl Acad Sci USA,1994年,91期,12208页

共引文献70

同被引文献97

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部